Related Videos
GS2-05 Update on the Combined TEXT and SOFT Trials
Dana-Farber's Meredith Regan, ScD presented an update on the SOFT/TEXT clinical trials at the 2021 San Antonio Breast Cancer Symposium.
ASCO22: Breast cancer research by Meredith Regan, ScD
Dana-Farber's Meredith Regan, ScD presents research looking at early treatment effects of adjuvant endocrine therapy for high-risk breast cancer at #ASCO22.
